BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 37272400)

  • 21. Liothyronine for hypothyroidism: a candidate for disinvestment or in need of further research? A value of information analysis.
    Hughes DA; Skiadas K; Fitzsimmons D; Anderson P; Heald A
    BMJ Open; 2021 Dec; 11(12):e051702. PubMed ID: 34862288
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treating hypothyroidism is not always easy: When to treat subclinical hypothyroidism, TSH goals in the elderly, and alternatives to levothyroxine monotherapy.
    Ross DS
    J Intern Med; 2022 Feb; 291(2):128-140. PubMed ID: 34766382
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Management of primary hypothyroidism: statement by the British Thyroid Association Executive Committee.
    Okosieme O; Gilbert J; Abraham P; Boelaert K; Dayan C; Gurnell M; Leese G; McCabe C; Perros P; Smith V; Williams G; Vanderpump M
    Clin Endocrinol (Oxf); 2016 Jun; 84(6):799-808. PubMed ID: 26010808
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sexual function and depressive symptoms in young women with hypothyroidism receiving levothyroxine/liothyronine combination therapy: a pilot study.
    Krysiak R; Szkróbka W; Okopień B
    Curr Med Res Opin; 2018 Sep; 34(9):1579-1586. PubMed ID: 29508635
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Liothyronine and Desiccated Thyroid Extract in the Treatment of Hypothyroidism.
    Idrees T; Palmer S; Maciel RMB; Bianco AC
    Thyroid; 2020 Oct; 30(10):1399-1413. PubMed ID: 32279609
    [No Abstract]   [Full Text] [Related]  

  • 26. The pharmacodynamic equivalence of levothyroxine and liothyronine: a randomized, double blind, cross-over study in thyroidectomized patients.
    Celi FS; Zemskova M; Linderman JD; Babar NI; Skarulis MC; Csako G; Wesley R; Costello R; Penzak SR; Pucino F
    Clin Endocrinol (Oxf); 2010 May; 72(5):709-15. PubMed ID: 20447070
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Prospective Study to Evaluate the Possible Role of Cholecalciferol Supplementation on Autoimmunity in Hashimoto's Thyroiditis.
    Bhakat B; Pal J; Das S; Charaborty SK; SircarMedical NR; Kolkata ; RGKar ; NorthBengal ; Siliguri
    J Assoc Physicians India; 2023 Jan; 71(1):1. PubMed ID: 37116030
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Liothyronine use in primary hypothyroidism - current concepts.
    Concepción-Zavaleta MJ; Ildefonso-Najarro SP; Paz-Ibarra JL; Valdivia Fernández-Dávila FR; Deutz Gómez-Condori DC; Rivera-Fabián KE; Herrera-Cabezas RG; Concepción-Urteaga LA
    Endokrynol Pol; 2021; 72(6):650-660. PubMed ID: 34855197
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Primary hypothyroidism and quality of life.
    Hegedüs L; Bianco AC; Jonklaas J; Pearce SH; Weetman AP; Perros P
    Nat Rev Endocrinol; 2022 Apr; 18(4):230-242. PubMed ID: 35042968
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hypothyroidism in adults. Levothyroxine if warranted by clinical and laboratory findings, not for simple TSH elevation.
    Prescrire Int; 2015 Oct; 24(164):241-4, 246. PubMed ID: 26594730
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prescribing Therapy for Hypothyroidism: Influence of Physician Characteristics.
    Jonklaas J; Tefera E; Shara N
    Thyroid; 2019 Jan; 29(1):44-52. PubMed ID: 30375273
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recent evidence sets therapeutic targets for levothyroxine-treated patients with primary hypothyroidism based on risk of death.
    Perros P; Nirantharakumar K; Hegedüs L
    Eur J Endocrinol; 2021 Feb; 184(2):C1-C3. PubMed ID: 33306038
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metabolic effects of liothyronine therapy in hypothyroidism: a randomized, double-blind, crossover trial of liothyronine versus levothyroxine.
    Celi FS; Zemskova M; Linderman JD; Smith S; Drinkard B; Sachdev V; Skarulis MC; Kozlosky M; Csako G; Costello R; Pucino F
    J Clin Endocrinol Metab; 2011 Nov; 96(11):3466-74. PubMed ID: 21865366
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Liothyronine (LT3) prescribing in England: Are cost constraints inhibiting guideline implementation?
    Ah H; Ld P; Pn T; Depesina D; Chaudhury N; Oe O; M S; Cm D
    Clin Endocrinol (Oxf); 2024 Jul; 101(1):62-68. PubMed ID: 38752469
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combination Thyroid Hormone Replacement; Knowns and Unknowns.
    Taylor PN; Eligar V; Muller I; Scholz A; Dayan C; Okosieme O
    Front Endocrinol (Lausanne); 2019; 10():706. PubMed ID: 31695677
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risks and safety of combination therapy for hypothyroidism.
    Jonklaas J
    Expert Rev Clin Pharmacol; 2016 Aug; 9(8):1057-67. PubMed ID: 27137849
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of Liothyronine Treatment on Quality of Life in Female Hypothyroid Patients With Residual Symptoms on Levothyroxine Therapy: A Randomized Crossover Study.
    Bjerkreim BA; Hammerstad SS; Gulseth HL; Berg TJ; Omdal LJ; Lee-Ødegård S; Eriksen EF
    Front Endocrinol (Lausanne); 2022; 13():816566. PubMed ID: 35273566
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Swinging Pendulum in Treatment for Hypothyroidism: From (and Toward?) Combination Therapy.
    McAninch EA; Bianco AC
    Front Endocrinol (Lausanne); 2019; 10():446. PubMed ID: 31354624
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Individualized Therapy for Hypothyroidism: Is T4 Enough for Everyone?
    Ettleson MD; Bianco AC
    J Clin Endocrinol Metab; 2020 Sep; 105(9):e3090-104. PubMed ID: 32614450
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ITALIAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS STATEMENT-REPLACEMENT THERAPY FOR PRIMARY HYPOTHYROIDISM: A BRIEF GUIDE FOR CLINICAL PRACTICE.
    Guglielmi R; Frasoldati A; Zini M; Grimaldi F; Gharib H; Garber JR; Papini E
    Endocr Pract; 2016 Nov; 22(11):1319-1326. PubMed ID: 27482609
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.